Thursday, August 27, 2020 10:48:24 AM
These guys might "punch above their weight", but they have a lot of work they are swallowing behind the scenes. If I'm not mistaken, we're still waiting on the peer review of the pre-print to complete for the 21 Expanded Access cases. They also have these things going on... OTC uplisting, hiring & HR stuff, trials/tracking, manufacturing partnership negotiations and planning, distribution partnership neg & plans, international considerations, legal crap, etc. just to name a few... AND... AND don't forget the huge political landscape they need to navigate, along with competitive positioning/partnering due to the enormous shift in wealth about to take place. I think we won't see the other trial results for another week or two at the earliest. Maybe I'll be pleasantly surprised.
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM